Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy

BJU International

Volumn 110, Issue 9, 2012, Pages 1270-1275

  Patel, Nilay ^a   Cranston, David ^a   Akhtar, M Zeeshan ^a   George, Caroline ^a   Jones, Andrew ^a   Leiblich, Aaron ^a   Protheroe, Andrew ^a   Sullivan, Mark ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

active surveillance; renal carcinoma; small mass

Indexed keywords

ACTIVE SURVEILLANCE; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER SPECIFIC SURVIVAL; CANCER THERAPY; CASE STUDY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; GROWTH RATE; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; KIDNEY BIOPSY; KIDNEY CARCINOMA; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METASTASIS; ONCOCYTOMA; OVERALL SURVIVAL; PARTIAL NEPHRECTOMY; PATIENT SAFETY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SMALL RENAL MASS; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR RECURRENCE; TUMOR VOLUME; VON HIPPEL LINDAU DISEASE;

EID: 85027945223     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11130.x     Document Type: Article

References (30)

1. Ferlay J, Parkin DM, Steliarova-Foucher E,. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010; 46: 765-81
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D,. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90
3. Mathew A, Devesa SS, Fraumeni JF, Chow W-H,. Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev 2002; 11: 171-8
4. Cooperberg MR, Mallin K, Ritchey J, Villalta JD, Carroll PR, Kane CJ,. Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004. J Urol 2008; 179: 2131-5
5. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK,. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006; 98: 1331-4
6. Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR,. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 2008; 113: 78-83
7. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ,. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49
8. Campbell SC, Novick AC, Belldegrun A, et al,. Guideline for management of the clinical T1 renal mass. J Urol 2009; 182: 1271-9
9. Ljungberg B, Cowan NC, Hanbury DC, et al,. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 2010; 58: 398-406
10. Cooperberg MR, Mallin K, Kane CJ, Carroll PR,. Treatment trends for stage I renal cell carcinoma. J Urol 2011; 186: 394-9
11. Kunkle DA, Egleston BL, Uzzo RG,. Excise, ablate or observe: the small renal mass dilemma-a meta-analysis and review. J Urol 2008; 179: 1227-33; discussion 1233-4
12. Charlesworth PJS, Kilbey N, Taylor M, et al,. Automated uro-oncology data collection: the Cancer Research Uro-Oncology Database. BJU Int 2010; 105: 1663-6
13. Smaldone MC, Kutikov A, Egleston BL, et al,. Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer 2011; 118: 997-1006
14. Jewett MAS, Mattar K, Basiuk J, et al,. Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol 2011; 60: 39-44
15. Crispen PL, Viterbo R, Boorjian SA, Greenberg RE, Chen DYT, Uzzo RG,. Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer 2009; 115: 2844-52
16. Kunkle DA, Crispen PL, Chen DYT, Greenberg RE, Uzzo RG,. Enhancing renal masses with zero net growth during active surveillance. J Urol 2007; 177: 849-53; discussion 853-4
17. Remzi M, Ozsoy M, Klingler HC, et al,. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol 2006; 176: 896-9
18. Haramis G, Mues AC, Rosales JC, et al,. Natural history of renal cortical neoplasms during active surveillance with follow-up longer than 5 years. Urology 2011; 77: 787-91
19. Rosales JC, Haramis G, Moreno J, et al,. Active surveillance for renal cortical neoplasms. J Urol 2010; 183: 1698-702
20. Kouba E, Smith A, McRackan D, Wallen EM, Pruthi RS,. Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention. J Urol 2007; 177: 466-70; discussion 470
21. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DYT, Uzzo RG,. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 2006; 175: 425-31
22. Kates M, Badalato GM, Pitman M, McKiernan JM,. Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or less. J Urol 2011; 186: 1247-53
23. Huang WC, Elkin EB, Levey AS, Jang TL, Russo P,. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors-is there a difference in mortality and cardiovascular outcomes? J Urol 2009; 181: 55-61; discussion 61-2
24. Thompson RH, Boorjian SA, Lohse CM, et al,. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 2008; 179: 468-71; discussion 472-3
25. Huang WC, Levey AS, Serio AM, et al,. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 2006; 7: 735-40
26. Kutikov A, Smaldone MC, Egleston BL, et al,. Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score. Eur Urol 2011; 60: 241-8
27. Phé V, Yates DR, Renard-Penna R, Cussenot O, Roupret M,. Is there a contemporary role for percutaneous needle biopsy in the era of small renal masses? BJU Int 2012; 109: 867-72
28. Leveridge MJ, Finelli A, Kachura JR, et al,. Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol 2011; 60: 578-84
29. Yates DR, Roupret M,. Small renal mass and low-risk prostate cancer: any more for active surveillance? Eur Urol 2011; 60: 45-7
30. Lane BR, Abouassaly R, Gao T, et al,. Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older. Cancer 2010; 116: 3119-26